alendronate has been researched along with Biliary Cirrhosis in 5 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate effectively increases bone mass and has greater antiresorptive power than etidronate in patients with primary biliary cirrhosis, and is associated with minor or no side effects." | 9.10 | Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. ( Alvarez, L; Caballería, L; Guañabens, N; Martínez de Osaba, MJ; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Ros, I, 2003) |
| "Osteoporosis resulting in bone fractures is a complication in patients with primary biliary cirrhosis (PBC)." | 6.78 | Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis. ( Cerdá, D; Gifre, L; Guañabens, N; Monegal, A; Muxí, Á; Parés, A; Peris, P, 2013) |
| "Alendronate effectively increases bone mass and has greater antiresorptive power than etidronate in patients with primary biliary cirrhosis, and is associated with minor or no side effects." | 5.10 | Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. ( Alvarez, L; Caballería, L; Guañabens, N; Martínez de Osaba, MJ; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Ros, I, 2003) |
| "Osteoporosis resulting in bone fractures is a complication in patients with primary biliary cirrhosis (PBC)." | 2.78 | Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis. ( Cerdá, D; Gifre, L; Guañabens, N; Monegal, A; Muxí, Á; Parés, A; Peris, P, 2013) |
| "Patients with primary biliary cirrhosis often have osteoporosis - either postmenopausal or secondary to the liver disease." | 2.47 | Bisphosphonates for osteoporosis in primary biliary cirrhosis. ( Bjelakovic, G; Giljaca, V; Gluud, C; Krstic, MN; Rudic, JS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guañabens, N | 2 |
| Monegal, A | 2 |
| Cerdá, D | 1 |
| Muxí, Á | 1 |
| Gifre, L | 1 |
| Peris, P | 2 |
| Parés, A | 2 |
| Rudic, JS | 1 |
| Giljaca, V | 1 |
| Krstic, MN | 1 |
| Bjelakovic, G | 1 |
| Gluud, C | 1 |
| Ros, I | 1 |
| Alvarez, L | 1 |
| Pons, F | 1 |
| Caballería, L | 1 |
| Martínez de Osaba, MJ | 1 |
| Roca, M | 1 |
| Rodés, J | 1 |
| Musialik, J | 1 |
| Petelenz, M | 1 |
| Gonciarz, Z | 1 |
| Zein, CO | 1 |
| Jorgensen, RA | 1 |
| Clarke, B | 1 |
| Wenger, DE | 1 |
| Keach, JC | 1 |
| Angulo, P | 1 |
| Lindor, KD | 1 |
1 review available for alendronate and Biliary Cirrhosis
| Article | Year |
|---|---|
Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Humans; Iband | 2011 |
3 trials available for alendronate and Biliary Cirrhosis
| Article | Year |
|---|---|
Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis.
Topics: Administration, Oral; Aged; Alendronate; Bone Density; Diphosphonates; Drug Administration Schedule; | 2013 |
Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis.
Topics: Adult; Aged; Alendronate; Bone Density; Bone Remodeling; Densitometry; Dose-Response Relationship, D | 2003 |
Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.
Topics: Aged; Alendronate; Biomarkers; Bone Density; Estrogen Replacement Therapy; Estrogens; Female; Femur; | 2005 |
1 other study available for alendronate and Biliary Cirrhosis
| Article | Year |
|---|---|
Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis: preliminary results after one year.
Topics: Absorptiometry, Photon; Aged; Alendronate; Bone Density; Bone Remodeling; Dose-Response Relationship | 2005 |